Kevin Phillip Weinfurt
Professor in Population Health Sciences
Education & Training
Ph.D., Georgetown University 1997
Kevin P. Weinfurt, PhD, is Professor and Vice Chair of Research in the Department of Population Health Sciences at Duke University Medical Center and a faculty member of the Duke Clinical Research Institute. He holds secondary appointment as a Professor of Psychology and Neuroscience, Professor of Psychiatry and Behavioral Sciences, Professor of Biostatistics and Bioinformatics, and a Faculty Associate of the Trent Center for the Study of Medical Humanities and Bioethics. Dr. Weinfurt also co-directs the Center for Health Measurement at Duke and is co-director of the Clinical Research Training Program (Masters degree offered through the School of Medicine).
Dr. Weinfurt conducts research on measuring patient-reported outcomes, medical decision making, and bioethics. In addition to conducting research, Dr. Weinfurt has taught undergraduate courses in introductory psychology, judgment and decision making, and the psychology of medical decision making; and graduate courses in multivariate statistics, patient-reported outcomes, and research ethics.
Areas of Expertise: Bioethics, Health Measurement, Health Services Research, and Health Behavior
Check, Devon K., et al. “Use of central institutional review boards for multicenter clinical trials in the United States: a review of the literature.” Clinical Trials (London, England), vol. 10, no. 4, Aug. 2013, pp. 560–67. Epmc, doi:10.1177/1740774513484393. Full Text
Flynn, Kathryn E., et al. “Participants' perspectives on safety monitoring in clinical trials.” Clin Trials, vol. 10, no. 4, Aug. 2013, pp. 552–59. Pubmed, doi:10.1177/1740774513484394. Full Text
Weinfurt, K. P. “Understanding What Participants in Empirical Bioethical Studies Mean: Historical Cautions From William James and Ludwig Wittgenstein.” Ajob Primary Research, vol. 4, no. 3, July 2013, pp. 49–54. Scopus, doi:10.1080/21507716.2013.807893. Full Text
Meropol, Neal J., et al. “A Web-based communication aid for patients with cancer: the CONNECT Study.” Cancer, vol. 119, no. 7, Apr. 2013, pp. 1437–45. Pubmed, doi:10.1002/cncr.27874. Full Text
Flynn, Kathryn E., et al. “Construct validity of the PROMIS® sexual function and satisfaction measures in patients with cancer.” Health Qual Life Outcomes, vol. 11, Mar. 2013, p. 40. Pubmed, doi:10.1186/1477-7525-11-40. Full Text
Kamble, Shital, et al. “Patient time costs associated with sensor-augmented insulin pump therapy for type 1 diabetes: results from the STAR 3 randomized trial.” Med Decis Making, vol. 33, no. 2, Feb. 2013, pp. 215–24. Pubmed, doi:10.1177/0272989X12464824. Full Text
Flynn, Kathryn E., et al. “Development of the NIH PROMIS ® Sexual Function and Satisfaction measures in patients with cancer.” J Sex Med, vol. 10 Suppl 1, Feb. 2013, pp. 43–52. Pubmed, doi:10.1111/j.1743-6109.2012.02995.x. Full Text
Flynn, Kathryn E., et al. “Using central IRBs for multicenter clinical trials in the United States.” Plos One, vol. 8, no. 1, 2013, p. e54999. Pubmed, doi:10.1371/journal.pone.0054999. Full Text
Weinfurt, Kevin P., et al. “Research participants' high expectations of benefit in early-phase oncology trials: are we asking the right question?” J Clin Oncol, vol. 30, no. 35, Dec. 2012, pp. 4396–400. Pubmed, doi:10.1200/JCO.2011.40.6587. Full Text